CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life
NCT07679074
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom tracking - on work productivity, employee wellbeing, and quality of life in individuals experiencing mood and cognitive symptoms associated with menstruation, perimenopause, or menopause.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Premenstrual Syndrome
- Premenstrual Dysphoric Disorder
- Dysmenorrhea
- Endometriosis
- Perimenopause
- Menopause
- Pelvic Pain
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 to 65 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Samphire Group, Inc.
- Last updated on ClinicalTrials.gov
- July 1, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Alethios Digital Research Platform (Decentralized) · San Francisco, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.